🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Autologous whole blood therapy

Found 1272 matching trials

Clinical Study of i-PRF Intrauterine Perfusion for Endometrial Regeneration and Repair in Moderate to Severe Intrauterine Adhesions

Intrauterine adhesions (IUA) caused by endometrial basal layer injury can l...

Status

Not Yet Recruiting

Location

Beijing obstetrics and gynecology hospital

Start Date

2026-05-01

Trial ID

NCT07536971

Treatments Being Tested

Injectable Platelet-Rich Fibrin Sodium Hyaluronate

Continuous Alloreactive T Cell Depletion and Regulatory T Cell Expansion for the Treatment of Steroid-refractory or Dependent Chronic GVHD

PHASE2

Phase II multicenter, Canadian only study - open to 25 subjects. Study open...

Status

Unknown

Location

Hospital Maissoneuve

Start Date

2016-03

Trial ID

NCT02519816

Treatments Being Tested

Autologous peripheral blood mononuclear cells ex vivo depleted for reactive T cells, using TH9402 based photodynamic therapy, in a final formulation of 10% DMSO, 30% autologous plasma in PlasmaLyte.

Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma

PHASE2

RATIONALE: Chemotherapy, such as busulfan, melphalan, and thiotepa, may des...

Status

Completed

Location

Knight Cancer Institute at Oregon Health and Science University

Start Date

2005-03

Trial ID

NCT00238433

Treatments Being Tested

filgrastim busulfan melphalan thiotepa bone marrow ablation with stem cell support peripheral blood stem cell transplantation

Efficacy Study of CD34 Stem Cell in Chronic Stroke Patients

PHASE2

The objective of the study is to determine the efficacy of brain transplant...

Status

Completed

Location

China Medical University Hospital

Start Date

2009-06

Trial ID

NCT00950521

Treatments Being Tested

Intercerebral implantation of Autulogous Stem Cells convention therapy

Intra-Articular PRP Versus Dexamethasone for TMJ Internal Derangement

This study looked at whether an injection into the jaw joint (temporomandib...

Status

Completed

Location

College of Dentistry, University of Anbar

Start Date

2025-12-10

Trial ID

NCT07691684

Treatments Being Tested

Platelet-Rich Plasma (PRP)Dexamethasone with Local Anaesthetic Normal Saline (Placebo)

Efficacy and Safety of Obinutuzumab Preemptive Treatment at the Time of the Molecular Relapse

PHASE2

The objective of the study is the evaluation of efficacy and safety of obin...

Status

Terminated

Location

Centrum Onkologii - Instytut im. Marii Skłodowskiej- Curie Klinika Nowotworów Układu Chłonnego

Start Date

2018-05-14

Trial ID

NCT03229382

Treatments Being Tested

Obinutuzumab

Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer

PHASE3

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...

Status

Completed

Location

Herbert Irving Comprehensive Cancer Center

Start Date

1996-05

Trial ID

NCT00008203

Treatments Being Tested

aldesleukin recombinant interferon gamma carboplatin cyclophosphamide cyclosporine thiotepa autologous bone marrow transplantation peripheral blood stem cell transplantation

Study of Lenalidomide/Dexamethasone With Nivolumab and Ipilimumab in Patients With Newly Diagnosed Multiple Myeloma

PHASE1

This study has 2 parts: a Dose Escalation Part and a Dose Expansion Part. ...

Status

Withdrawn

Location

Multiple Locations

Start Date

2017-10

Trial ID

NCT03283046

Treatments Being Tested

Nivolumab Lenalidomide Dexamethasone Ipilimumab

Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma

PHASE2

This phase II trial tests how well giving dasatinib and quercetin with cycl...

Status

Recruiting

Location

Mayo Clinic in Rochester

Start Date

2025-09-18

Trial ID

NCT06940297

Treatments Being Tested

Biopsy Procedure Biospecimen Collection Bone Marrow Aspiration Bone Marrow Biopsy Ciltacabtagene Autoleucel Computed Tomography Cyclophosphamide Dasatinib Fludarabine Positron Emission Tomography Quercetin

Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations

PHASE1

This phase I trial studies the side effects and best dose of autologous CD8...

Status

Recruiting

Location

Fred Hutch/University of Washington Cancer Consortium

Start Date

2023-12-15

Trial ID

NCT06043713

Treatments Being Tested

Bendamustine Biopsy Biospecimen Collection Computed Tomography Cyclophosphamide Echocardiography Fludarabine Leukapheresis Magnetic Resonance Imaging Multigated Acquisition Scan Positron Emission Tomography T-cell Receptor-engineered T-cells

Previous Next